TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression

Hepatic ischemia–reperfusion (IR) injury is a serious clinical problem that complicates liver resection and transplantation. Despite recent advances in understanding of the pathophysiology of hepatic IR injury, effective interventions and therapeutics are still lacking. Here, we examined the role of...

Full description

Bibliographic Details
Main Authors: Cheng Zhong, Jing Yang, Yiyin Zhang, Xiaoxiao Fan, Yang Fan, Ning Hua, Duguang Li, Shengxi Jin, Yirun Li, Peng Chen, Yongle Chen, Xiaobo Cai, Yi Zhang, Linhua Jiang, Wei Yang, Peilin Yu, Hui Lin
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2023-01-01
Series:Research
Online Access:https://spj.science.org/doi/10.34133/research.0159
_version_ 1827297415136280576
author Cheng Zhong
Jing Yang
Yiyin Zhang
Xiaoxiao Fan
Yang Fan
Ning Hua
Duguang Li
Shengxi Jin
Yirun Li
Peng Chen
Yongle Chen
Xiaobo Cai
Yi Zhang
Linhua Jiang
Wei Yang
Peilin Yu
Hui Lin
author_facet Cheng Zhong
Jing Yang
Yiyin Zhang
Xiaoxiao Fan
Yang Fan
Ning Hua
Duguang Li
Shengxi Jin
Yirun Li
Peng Chen
Yongle Chen
Xiaobo Cai
Yi Zhang
Linhua Jiang
Wei Yang
Peilin Yu
Hui Lin
author_sort Cheng Zhong
collection DOAJ
description Hepatic ischemia–reperfusion (IR) injury is a serious clinical problem that complicates liver resection and transplantation. Despite recent advances in understanding of the pathophysiology of hepatic IR injury, effective interventions and therapeutics are still lacking. Here, we examined the role of transient receptor potential melastatin 2 (TRPM2), a Ca2+-permeable, non-selective cation channel, in mediating hepatic IR injury. Our data showed that TRPM2 deficiency attenuated IR-induced liver dysfunction, inflammation, and cell death in mice. Moreover, RNA sequencing analysis indicated that TRPM2-induced IR injury occurs via ferroptosis-related pathways. Consistently, as a ferroptosis inducer, (1S,3R)-RSL3 treatment induced mitochondrial dysfunction in hepatocytes and a TRPM2 inhibitor suppressed this. Interestingly, TRPM2-mediated calcium influx caused mitochondrial calcium accumulation via the mitochondrial Ca2+-selective uniporter and increased the expression level of arachidonate 12-lipoxygenase (ALOX12), which results in mitochondrial lipid peroxidation during hepatic IR injury. Furthermore, hepatic IR injury-induced ferroptosis was obviously relieved by a TRPM2 inhibitor or calcium depletion, both in vitro and in vivo. Collectively, these findings demonstrate a crucial role for TRPM2-mediated ferroptosis in hepatic IR injury via increased Ca2+-induced ALOX12 expression, indicating that pharmacological inhibition of TRPM2 may provide an effective therapeutic strategy for hepatic IR injury-related diseases, such as during liver resection and transplantation.
first_indexed 2024-03-13T08:08:34Z
format Article
id doaj.art-9dd57fc864dd49c98fde430f99396002
institution Directory Open Access Journal
issn 2639-5274
language English
last_indexed 2024-04-24T14:55:50Z
publishDate 2023-01-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Research
spelling doaj.art-9dd57fc864dd49c98fde430f993960022024-04-02T19:12:34ZengAmerican Association for the Advancement of Science (AAAS)Research2639-52742023-01-01610.34133/research.0159TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 ExpressionCheng Zhong0Jing Yang1Yiyin Zhang2Xiaoxiao Fan3Yang Fan4Ning Hua5Duguang Li6Shengxi Jin7Yirun Li8Peng Chen9Yongle Chen10Xiaobo Cai11Yi Zhang12Linhua Jiang13Wei Yang14Peilin Yu15Hui Lin16Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of Toxicology and Department of Medical Oncology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.Department of Physiology and Pathophysiology and Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Xinxiang Medical University, 453003 Xinxiang, Henan, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Department of Biophysics and Department of Neurology of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, P.R. China.Department of Biophysics and Department of Neurology of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, P.R. China.Department of Physiology and Pathophysiology and Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Xinxiang Medical University, 453003 Xinxiang, Henan, P.R. China.Department of Biophysics and Department of Neurology of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, P.R. China.Department of Toxicology and Department of Medical Oncology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.Hepatic ischemia–reperfusion (IR) injury is a serious clinical problem that complicates liver resection and transplantation. Despite recent advances in understanding of the pathophysiology of hepatic IR injury, effective interventions and therapeutics are still lacking. Here, we examined the role of transient receptor potential melastatin 2 (TRPM2), a Ca2+-permeable, non-selective cation channel, in mediating hepatic IR injury. Our data showed that TRPM2 deficiency attenuated IR-induced liver dysfunction, inflammation, and cell death in mice. Moreover, RNA sequencing analysis indicated that TRPM2-induced IR injury occurs via ferroptosis-related pathways. Consistently, as a ferroptosis inducer, (1S,3R)-RSL3 treatment induced mitochondrial dysfunction in hepatocytes and a TRPM2 inhibitor suppressed this. Interestingly, TRPM2-mediated calcium influx caused mitochondrial calcium accumulation via the mitochondrial Ca2+-selective uniporter and increased the expression level of arachidonate 12-lipoxygenase (ALOX12), which results in mitochondrial lipid peroxidation during hepatic IR injury. Furthermore, hepatic IR injury-induced ferroptosis was obviously relieved by a TRPM2 inhibitor or calcium depletion, both in vitro and in vivo. Collectively, these findings demonstrate a crucial role for TRPM2-mediated ferroptosis in hepatic IR injury via increased Ca2+-induced ALOX12 expression, indicating that pharmacological inhibition of TRPM2 may provide an effective therapeutic strategy for hepatic IR injury-related diseases, such as during liver resection and transplantation.https://spj.science.org/doi/10.34133/research.0159
spellingShingle Cheng Zhong
Jing Yang
Yiyin Zhang
Xiaoxiao Fan
Yang Fan
Ning Hua
Duguang Li
Shengxi Jin
Yirun Li
Peng Chen
Yongle Chen
Xiaobo Cai
Yi Zhang
Linhua Jiang
Wei Yang
Peilin Yu
Hui Lin
TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
Research
title TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
title_full TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
title_fullStr TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
title_full_unstemmed TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
title_short TRPM2 Mediates Hepatic Ischemia–Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression
title_sort trpm2 mediates hepatic ischemia reperfusion injury via ca2 induced mitochondrial lipid peroxidation through increasing alox12 expression
url https://spj.science.org/doi/10.34133/research.0159
work_keys_str_mv AT chengzhong trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT jingyang trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT yiyinzhang trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT xiaoxiaofan trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT yangfan trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT ninghua trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT duguangli trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT shengxijin trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT yirunli trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT pengchen trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT yonglechen trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT xiaobocai trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT yizhang trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT linhuajiang trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT weiyang trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT peilinyu trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression
AT huilin trpm2mediateshepaticischemiareperfusioninjuryviaca2inducedmitochondriallipidperoxidationthroughincreasingalox12expression